CN101563319B - 杂芳基吡咯烷基和哌啶基甲酮衍生物 - Google Patents

杂芳基吡咯烷基和哌啶基甲酮衍生物 Download PDF

Info

Publication number
CN101563319B
CN101563319B CN2007800471648A CN200780047164A CN101563319B CN 101563319 B CN101563319 B CN 101563319B CN 2007800471648 A CN2007800471648 A CN 2007800471648A CN 200780047164 A CN200780047164 A CN 200780047164A CN 101563319 B CN101563319 B CN 101563319B
Authority
CN
China
Prior art keywords
ketone
tetramethyleneimine
phenyl
chloro
propyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN2007800471648A
Other languages
English (en)
Chinese (zh)
Other versions
CN101563319A (zh
Inventor
P·耶尔
C·J·J·林
M·C·卢卡斯
S·M·兰什
A·M·马德拉
K·E·厄兹伯雅
R·J·韦克特
R·C·舍恩菲尔德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39262542&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN101563319(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CN101563319A publication Critical patent/CN101563319A/zh
Application granted granted Critical
Publication of CN101563319B publication Critical patent/CN101563319B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Seasonings (AREA)
CN2007800471648A 2006-12-19 2007-12-11 杂芳基吡咯烷基和哌啶基甲酮衍生物 Active CN101563319B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US87596906P 2006-12-19 2006-12-19
US60/875,969 2006-12-19
US99956107P 2007-10-19 2007-10-19
US60/999,561 2007-10-19
PCT/EP2007/063736 WO2008074703A1 (en) 2006-12-19 2007-12-11 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives

Publications (2)

Publication Number Publication Date
CN101563319A CN101563319A (zh) 2009-10-21
CN101563319B true CN101563319B (zh) 2012-09-05

Family

ID=39262542

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007800471648A Active CN101563319B (zh) 2006-12-19 2007-12-11 杂芳基吡咯烷基和哌啶基甲酮衍生物

Country Status (30)

Country Link
US (2) US8084623B2 (https=)
EP (3) EP2102157B1 (https=)
JP (1) JP5394252B2 (https=)
KR (1) KR101054189B1 (https=)
CN (1) CN101563319B (https=)
AR (1) AR064397A1 (https=)
AT (1) ATE513808T1 (https=)
BR (1) BRPI0720742B8 (https=)
CA (1) CA2671378C (https=)
CL (1) CL2007003672A1 (https=)
CO (1) CO6190531A2 (https=)
CR (1) CR10809A (https=)
CY (1) CY1113916T1 (https=)
DK (1) DK2354124T3 (https=)
EC (1) ECSP099442A (https=)
ES (2) ES2366980T3 (https=)
HR (1) HRP20130362T1 (https=)
IL (1) IL198879A0 (https=)
MA (1) MA31142B1 (https=)
MX (1) MX2009006334A (https=)
MY (1) MY186650A (https=)
NO (1) NO20092058L (https=)
NZ (1) NZ577114A (https=)
PE (2) PE20081831A1 (https=)
PL (1) PL2354124T3 (https=)
PT (1) PT2354124E (https=)
RU (1) RU2479575C2 (https=)
SG (1) SG170054A1 (https=)
TW (1) TWI377202B (https=)
WO (1) WO2008074703A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009115427A1 (en) * 2008-03-20 2009-09-24 F. Hoffmann-La Roche Ag Pyrrolidinyl derivatives and uses thereof
AU2009259492A1 (en) * 2008-06-18 2009-12-23 F. Hoffmann-La Roche Ag Aryl ketone as MRI
CA2749309C (en) 2009-02-09 2018-01-09 Sunovion Pharmaceuticals Inc. Pyrrolidine triple reuptake inhibitors
JP5992192B2 (ja) * 2012-03-30 2016-09-14 三井金属鉱業株式会社 パラジウム触媒
RU2014145806A (ru) * 2012-04-25 2016-06-10 Ф. Хоффманн-Ля Рош Аг Способы производства (3,4-дихлорфенил)-((s)-3-пропил-пирролидин-3-ил)-метанонгидрохлорида
WO2014134391A1 (en) 2013-02-28 2014-09-04 Bristol-Myers Squibb Company Phenylpyrazole derivatives as potent rock1 and rock2 inhibitors
AR094929A1 (es) 2013-02-28 2015-09-09 Bristol Myers Squibb Co Derivados de fenilpirazol como inhibidores potentes de rock1 y rock2
CN110642880B (zh) * 2019-10-11 2021-12-31 长沙麓兴生物科技有限公司 一种氮未取代吡唑和吲唑类硼酸的制备方法
CN114014792B (zh) * 2021-12-15 2024-01-26 沈阳海诺威医药科技有限公司 一种7-(4-溴苯甲酰基)-1,3-二氢-2h-吲哚-2-酮的制备方法
WO2023161533A1 (en) 2022-02-28 2023-08-31 Noema Pharma Ag Triple uptake inhibitor for the treatment of atypical depression
CN116751157B (zh) * 2023-06-21 2025-09-12 上海再启生物技术有限公司 一种2-(2-氨基-5-溴-苯甲酰基)吡啶的放大制备方法
WO2025045932A1 (en) 2023-08-28 2025-03-06 Noema Pharma Ag A triple reuptake inhibitor for use in methods of treating a behavioral immuno-metabolic cluster condition or disorder
WO2025046050A1 (en) * 2023-08-30 2025-03-06 Noema Pharma Ag Methods of treating a sleep disorder using a triple reuptake inhibitor
WO2025106383A1 (en) * 2023-11-17 2025-05-22 Merck Sharp & Dohme Llc Pyrrolidinyl derivatives useful as hcn1/hcn 2 modulators
WO2025146469A1 (en) * 2024-01-05 2025-07-10 Noema Pharma Ag Treatment for the symptoms of menopause and perimenopause

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2248018A (en) * 1939-03-30 1941-07-01 Winthrop Chem Co Inc 4-aryl-piperidine-ketones and a process of preparing them
BE601228A (nl) * 1960-03-14 1961-07-03 Paul Adriaan Jan Janssen Nieuwe 1-aroylalkyl-4-arylpiperidine-carboxamiden en werkwijzen ter bereiding daarvan
WO1997019073A1 (en) * 1995-11-17 1997-05-29 Merck Sharp & Dohme Limited Piperidine and tetrahydropyridine derivatives
WO2004024720A1 (en) * 2002-09-11 2004-03-25 Merck & Co., Inc. Piperazine urea derivatives as melanocortin-4 receptor agonists
WO2005047253A1 (en) * 2003-11-12 2005-05-26 Lg Life Sciences Ltd. Melanocortin receptor agonists

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3073829A (en) * 1963-01-15 Certificate of correction
US3056795A (en) * 1958-04-30 1962-10-02 Sterling Drug Inc 3-aryl-3-(aroyl or alkanoyl)tropanes and preparation thereof
US4341698A (en) * 1979-06-21 1982-07-27 Richardson-Merrell Inc. Enkaphalin derivatives
GB2060937A (en) 1979-10-12 1981-05-07 Rolls Royce Fluid-flow restrictor assembly
ZA806501B (en) * 1979-10-27 1981-10-28 Richardson Merrell Inc 4-(4-alkyl-aroyl-1-piperidino)butyrophenone antipsychotic agents
US4443451A (en) * 1981-07-15 1984-04-17 Janssen Pharmaceutica N.V. Bicyclic pyrimidin-5-one derivatives
CA1228867A (en) 1984-05-03 1987-11-03 Celanese Corporation Methanol carbonylation process
EP0507863A4 (en) 1989-12-28 1993-07-07 Virginia Commonwealth University Sigma receptor ligands and the use thereof
IL117149A0 (en) 1995-02-23 1996-06-18 Schering Corp Muscarinic antagonists
FR2735127B1 (fr) 1995-06-09 1997-08-22 Pf Medicament Nouvelles piperazines heteroaromatiques utiles comme medicaments.
FR2758327B1 (fr) 1997-01-15 1999-04-02 Pf Medicament Nouvelles arylpiperazines derivees de piperidine
NZ506465A (en) * 1998-02-26 2003-08-29 Akzo Nobel Nv Derivatives of azetidine and pyrrolidine
WO2001014331A2 (en) 1999-08-24 2001-03-01 Regents Of The University Of California Non-quinoline inhibitors of malaria parasites
US20020151712A1 (en) * 1999-09-14 2002-10-17 Nan-Horng Lin 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission
EP1218336A2 (en) * 1999-09-20 2002-07-03 Takeda Chemical Industries, Ltd. Melanin concentrating hormone antagonist
EP1242080A4 (en) * 1999-09-27 2003-01-22 Univ Georgetown DOPAMINE TRANSPORTER INHIBITORS AND THEIR USE
CA2422055A1 (en) 2000-09-11 2002-03-21 Sepracor, Inc. Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
WO2002072548A2 (en) 2001-03-09 2002-09-19 Ortho-Mcneil Pharmaceutical, Inc. Heterocyclic compounds and their use as histamine h4 ligands.
US6569887B2 (en) * 2001-08-24 2003-05-27 Dov Pharmaceuticals Inc. (−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake
US20030236277A1 (en) 2002-02-14 2003-12-25 Kadow John F. Indole, azaindole and related heterocyclic pyrrolidine derivatives
TW200403058A (en) 2002-04-19 2004-03-01 Bristol Myers Squibb Co Heterocyclo inhibitors of potassium channel function
US20040034019A1 (en) 2002-08-08 2004-02-19 Ronald Tomlinson Piperazine and piperidine derivatives
CA2497408A1 (en) 2002-09-03 2004-03-18 Sarvajit Chakravarty Indole-type derivatives as inhibitors of p38 kinase
CA2501611A1 (en) 2002-10-11 2004-04-22 Astrazeneca Ab 1,4-disubstituted piperidine derivatives and their use as 11-betahsd1 inhibitors
WO2004080925A2 (en) 2003-03-12 2004-09-23 The University Of Western Ontario Synthesis of tetrahydro-1,2-oxazines by the cycloaddition of nitrones with cyclopropanes
US20060014987A1 (en) 2003-07-07 2006-01-19 Lan Huang Synthesis of beta-elemene, intermediates thereto, analogues and uses thereof
JP2005057154A (ja) * 2003-08-07 2005-03-03 Canon Inc 露光装置
RU2006117631A (ru) 2003-10-24 2007-12-10 Ф.Хоффманн-Ля Рош Аг (Ch) Антагонисты рецептора ссr3
GB0325745D0 (en) 2003-11-05 2003-12-10 Astrazeneca Ab Chemical compounds
WO2005082904A1 (ja) 2004-02-26 2005-09-09 Kyowa Hakko Kogyo Co., Ltd. 好中球性炎症疾患の予防及び／または治療剤
DK1761519T3 (da) 2004-06-21 2008-07-21 Hoffmann La Roche Indolderivater som histaminreceptorantagonister
SG154433A1 (en) 2004-06-30 2009-08-28 Janssen Pharmaceutica Nv Phthalazine derivatives as parp inhibitors
US7829712B2 (en) 2004-09-20 2010-11-09 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase
US20060167044A1 (en) * 2004-12-20 2006-07-27 Arnaiz Damian O Piperidine derivatives and their use as anti-inflammatory agents
DE102004061934A1 (de) 2004-12-22 2006-07-13 Siemens Ag Verfahren zur Datenübertragung zwischen einer sendenden und einer empfangenden Einheit in einem Bluetooth-Funkkommunikationssystem
WO2006081332A1 (en) 2005-01-25 2006-08-03 Epix Delaware, Inc. Substituted arylamine compounds and their use as 5-ht6 modulators
WO2006086609A2 (en) 2005-02-10 2006-08-17 Axys Pharmaceuticals, Inc. Inhibitors of tryptase
US7947686B2 (en) 2005-12-12 2011-05-24 Nerviano Medical Sciences S.R.L. Substituted pyrazolo[4,3-c]pyridine derivatives active as kinase inhibitors
US7544698B2 (en) 2006-04-07 2009-06-09 Janssen Pharmaceutica, N.V. Indoles and benzoimidazoles as modulators of the histamine H4 receptor

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2248018A (en) * 1939-03-30 1941-07-01 Winthrop Chem Co Inc 4-aryl-piperidine-ketones and a process of preparing them
BE601228A (nl) * 1960-03-14 1961-07-03 Paul Adriaan Jan Janssen Nieuwe 1-aroylalkyl-4-arylpiperidine-carboxamiden en werkwijzen ter bereiding daarvan
WO1997019073A1 (en) * 1995-11-17 1997-05-29 Merck Sharp & Dohme Limited Piperidine and tetrahydropyridine derivatives
WO2004024720A1 (en) * 2002-09-11 2004-03-25 Merck & Co., Inc. Piperazine urea derivatives as melanocortin-4 receptor agonists
WO2005047253A1 (en) * 2003-11-12 2005-05-26 Lg Life Sciences Ltd. Melanocortin receptor agonists

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
David I.C.Scopes等.New κ-Receptor Agonists Based upon a 2-[(Alkylamino)methyl]piperidine Nucleus.《J.MED.CHEM》.1992,第35卷(第3期),490-501. *
Dieter Seebach等.Alkylation of Amino Acids without Loss of the Optical Activity: Preparation of α-Substituted Proline Derivatives.A Case of Self-Reproduction of Chirality.《J.AM.CHEM.SOC》.1983,第105卷(第16期),5390-5398. *
Jerry Isaacson等.Expeditious Access to Unprotected Racemic.《J.ORG.CHEM》.2007,第72卷(第10期),第3914页图1化合物4. *
Jill B. Rhoden等.Structure–activity studies of 30-40-dichloro-meperidine analogues.《Bioorganic & Medicinal Chemistry》.2005,第13卷(第19期),5623–5634. *
Masazumi Ikeda等.A Formal Total Synthesis of (-)-Cephalotaxine.《Chem.Pharm.Bull》.1999,第47卷(第7期),983-987. *
Peter J. Wagner.Absence of intramolecular Charge-Transfer Quenching in PHotoexcited 4-Benzoylpiperidines.《J.AM.CHEM.SOC》.1977,第99卷1858-1863. *
Rescarch Laboratorics等.Studies of piperidine Derivatives.⒈.《J.MED.CHEM》.1970,第13卷(第4期),644-648. *
Timothy P. Burkholder等.SYNTHESIS AND STRUCTURE--ACTIVITY RELATIONSHIPS FOR A.《Bioorganic & Medicinal Chemistry Letter》.1997,第7卷(第19期),2531-253. *
Yoshifumi Watanabe.Syntheses and 5-HT2 Antagonist Activity of Bicyclic 1,2,4-Triazol-3(2H)-one and.《J.MED.CHEM》.1991,第35卷(第1期),189-194. *

Also Published As

Publication number Publication date
KR101054189B1 (ko) 2011-08-03
CR10809A (es) 2009-06-25
CN101563319A (zh) 2009-10-21
JP2010513379A (ja) 2010-04-30
RU2479575C2 (ru) 2013-04-20
NZ577114A (en) 2011-12-22
WO2008074703A1 (en) 2008-06-26
DK2354124T3 (da) 2013-03-11
MX2009006334A (es) 2009-06-23
US20120065225A1 (en) 2012-03-15
TWI377202B (en) 2012-11-21
ATE513808T1 (de) 2011-07-15
MY186650A (en) 2021-08-03
TW200838859A (en) 2008-10-01
ECSP099442A (es) 2009-07-31
HRP20130362T1 (en) 2013-05-31
EP2102157A1 (en) 2009-09-23
BRPI0720742B8 (pt) 2021-05-25
US20080146607A1 (en) 2008-06-19
EP2354124B1 (en) 2013-02-13
CY1113916T1 (el) 2016-07-27
EP2684871B1 (en) 2016-05-04
PL2354124T3 (pl) 2013-07-31
NO20092058L (no) 2009-09-17
PT2354124E (pt) 2013-04-09
KR20090091194A (ko) 2009-08-26
ES2401129T3 (es) 2013-04-17
CA2671378A1 (en) 2008-06-26
AR064397A1 (es) 2009-04-01
BRPI0720742A2 (pt) 2014-01-28
PE20121151A1 (es) 2012-08-27
EP2684871A1 (en) 2014-01-15
IL198879A0 (en) 2010-02-17
MA31142B1 (fr) 2010-02-01
BRPI0720742B1 (pt) 2021-02-09
US8513425B2 (en) 2013-08-20
EP2354124A3 (en) 2011-09-14
CL2007003672A1 (es) 2008-07-25
RU2009122666A (ru) 2011-01-27
PE20081831A1 (es) 2008-12-27
US8084623B2 (en) 2011-12-27
SG170054A1 (en) 2011-04-29
JP5394252B2 (ja) 2014-01-22
CO6190531A2 (es) 2010-08-19
ES2366980T3 (es) 2011-10-27
EP2102157B1 (en) 2011-06-22
EP2354124A2 (en) 2011-08-10
CA2671378C (en) 2015-10-20
AU2007336375A1 (en) 2008-06-26

Similar Documents

Publication Publication Date Title
CN101563319B (zh) 杂芳基吡咯烷基和哌啶基甲酮衍生物
CN101027297B (zh) 大环β-分泌酶抑制剂
ES2445536T3 (es) Derivados de la pirazina y su uso en el tratamiento de trastornos neurológicos
US9630976B2 (en) Compound having agonistic activity on somatostatin receptor, and use thereof for medical purposes
EP2663559B1 (en) Oxazine derivatives and their use in the treatment of neurological disorders
ES2375586T3 (es) Derivados de imidazolidinona.
CN102066320A (zh) 作为mri的芳基甲酮
CN101479250A (zh) 四唑取代的芳基酰胺类
CN110483492A (zh) 二肽基肽酶i抑制剂
KR20110128206A (ko) 치환된 ２-아세트아미도-５-아릴-１,２,４-트리아졸론 및 그의 용도
TW201211038A (en) Oxazine derivatives and their use in the treatment of neurological disorders
HRP20041008A2 (en) Triazole derivatives as tachykinin receptor antagonists
TW200538440A (en) Muscarinic acetylcholine receptor antagonists
CN104470930A (zh) 杂环化合物和它们的使用方法
ES2311721T3 (es) Indoles sustituidos en posicion 2,4 y su empleo como moduladores de 5-ht6.
US20070270411A1 (en) Novel Diazepine Compounds as Ligands of the Melanocortin 1 and/or 4 Receptors
JP2007517857A (ja) 治療に有用な化合物
CN101977907A (zh) 吡咯烷基衍生物及其用途
US8674115B2 (en) CRTH2 modulators
CN102099031A (zh) 被取代的吲哚基和吲唑基衍生物及其应用
CN103119027A (zh) 取代的苯乙酰胺和苯丙酰胺及其用途
TWI553013B (zh) 作為Ｖ１ａ拮抗劑之氧基－環己基－４Ｈ，６Ｈ－５－氧雜－２，３，１０ｂ－三氮雜－苯并［ｅ］薁
CN101123962A (zh) 可诱导一氧化氮合成酶二聚化的抑制剂
CN108424414A (zh) 一类含杂环的吲哚胺2，3-双加氧酶调节化合物及其在药学中的用途
HK1193602A (en) Oxy-cyclohexyl-4h,6h-5-oxa-2,3,10b-triaza-benzo[e]azulenes as v1a antagonists

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant